PL3102228T3 - Ultraczyste, hipoalergiczne roztwory sakrozydazy - Google Patents

Ultraczyste, hipoalergiczne roztwory sakrozydazy

Info

Publication number
PL3102228T3
PL3102228T3 PL15706592T PL15706592T PL3102228T3 PL 3102228 T3 PL3102228 T3 PL 3102228T3 PL 15706592 T PL15706592 T PL 15706592T PL 15706592 T PL15706592 T PL 15706592T PL 3102228 T3 PL3102228 T3 PL 3102228T3
Authority
PL
Poland
Prior art keywords
sacrosidase
solutions
hypoallergenic
ultrapure
ultrapure hypoallergenic
Prior art date
Application number
PL15706592T
Other languages
English (en)
Inventor
Dayton T. Reardan
Christopher SEEKAMP
Original Assignee
Qol Medical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qol Medical Llc filed Critical Qol Medical Llc
Publication of PL3102228T3 publication Critical patent/PL3102228T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2431Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0101Oligo-1,6-glucosidase (3.2.1.10), i.e. sucrase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22Cysteine endopeptidases (3.4.22)
    • C12Y304/22002Papain (3.4.22.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
PL15706592T 2014-02-07 2015-02-06 Ultraczyste, hipoalergiczne roztwory sakrozydazy PL3102228T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/175,263 US9255261B2 (en) 2014-02-07 2014-02-07 Ultrapure hypoallergenic solutions of sacrosidase
EP15706592.1A EP3102228B1 (en) 2014-02-07 2015-02-06 Ultrapure hypoallergenic solutions of sacrosidase
PCT/US2015/014837 WO2015120284A1 (en) 2014-02-07 2015-02-06 Ultrapure hypoallergenic solutions of sacrosidase

Publications (1)

Publication Number Publication Date
PL3102228T3 true PL3102228T3 (pl) 2019-05-31

Family

ID=52589778

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15706592T PL3102228T3 (pl) 2014-02-07 2015-02-06 Ultraczyste, hipoalergiczne roztwory sakrozydazy
PL18175578T PL3417873T3 (pl) 2014-02-07 2015-02-06 Ultraczyste hipoalergiczne roztwory sakrozydazy

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18175578T PL3417873T3 (pl) 2014-02-07 2015-02-06 Ultraczyste hipoalergiczne roztwory sakrozydazy

Country Status (8)

Country Link
US (4) US9255261B2 (pl)
EP (2) EP3102228B1 (pl)
CA (1) CA2938733C (pl)
DK (2) DK3417873T3 (pl)
ES (2) ES2765507T3 (pl)
PL (2) PL3102228T3 (pl)
TR (1) TR201815539T4 (pl)
WO (1) WO2015120284A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9255261B2 (en) 2014-02-07 2016-02-09 Qol Medical Llc Ultrapure hypoallergenic solutions of sacrosidase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786014A (en) 1952-09-10 1957-03-19 James L Tullis Platelet preservation
US4189401A (en) 1978-07-17 1980-02-19 Beckman Instruments, Inc. Method of storing a biological reference control standard and biological reference control standard obtained thereby
US4423600A (en) 1982-12-10 1984-01-03 Mckenna Joan J Method for preservation of living organic tissue by freezing
US4688387A (en) 1985-11-12 1987-08-25 Vital Force, Inc. Method for preservation and storage of viable biological materials at cryogenic temperatures
DE3915616C1 (pl) 1989-05-12 1990-06-21 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig, De
MXPA04000698A (es) 2004-01-23 2005-07-27 Inst Politecnico Nacional Hidrolisis de sacarosa por candida lactis-condensi mpiiia e invertasa de la misma.
ES2303421B1 (es) 2005-12-26 2009-06-17 Universidad Autonoma De Madrid Nueva actividad fructofuranosidasa para la obtencion del oligosacarido prebiotico 6-kestosa.
US20140250942A1 (en) 2013-03-06 2014-09-11 Qol Medical Llc Stable solutions of sacrosidase
US9255261B2 (en) 2014-02-07 2016-02-09 Qol Medical Llc Ultrapure hypoallergenic solutions of sacrosidase

Also Published As

Publication number Publication date
US9469847B2 (en) 2016-10-18
EP3417873A1 (en) 2018-12-26
EP3102228B1 (en) 2018-08-29
CA2938733A1 (en) 2015-08-13
EP3417873B1 (en) 2019-10-16
CA2938733C (en) 2023-04-04
US20150343032A1 (en) 2015-12-03
US10588947B2 (en) 2020-03-17
ES2692419T3 (es) 2018-12-03
EP3102228A1 (en) 2016-12-14
DK3417873T3 (da) 2020-01-27
PL3417873T3 (pl) 2020-05-18
US20170000860A1 (en) 2017-01-05
WO2015120284A1 (en) 2015-08-13
ES2765507T3 (es) 2020-06-09
US9255261B2 (en) 2016-02-09
US20150225707A1 (en) 2015-08-13
US9849161B2 (en) 2017-12-26
DK3102228T3 (en) 2018-11-05
TR201815539T4 (tr) 2018-11-21
US20180193433A1 (en) 2018-07-12

Similar Documents

Publication Publication Date Title
SG11201609265RA (en) Characterizing states of subject
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
AP00774S1 (en) Earphone
GB201408751D0 (en) Notifications
GB201413018D0 (en) Beyond 1A
SG11201701819PA (en) First entry notification
SG11201700080SA (en) Ultrafiltration of polyisoolefin copolymers
SI3154526T1 (sl) Trdne oblike sofosbuvira
GB2529705B (en) Message processing
GB2525637B (en) Message Processing
PT3212643T (pt) Álcoois trifluorometílicos como moduladores de ror-gama-t
ZA201606066B (en) Reception and generation of light
IL246979A0 (en) Crystalline forms of sofosbuvir
PL2902575T3 (pl) System okuciowy
GB2529417B (en) Communications device
GB201412010D0 (en) Treatment of hypertransaminasemia
PL3417873T3 (pl) Ultraczyste hipoalergiczne roztwory sakrozydazy
IL249332A0 (en) Crystalline forms of sofosbuvir
PH32014001218S1 (en) Sachet
GB201416053D0 (en) Secure communications
PL3137475T3 (pl) Oczyszczanie epidaunorubicyny
PT2923578T (pt) Método para a produção de um produto alimentar
GB201404819D0 (en) The theory of creation & magnate
GB201416201D0 (en) Guardian
IL234315A0 (en) best wishes